« Previous
Next »
The American Journal of Medicine
Volume 121, Issue 8
, Pages 709-714
, August 2008
Clinical Significance and Predictors of Community-Onset Pseudomonas aeruginosa Bacteremia
References
- Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes. Arch Intern Med. 2000;160(4):501–509
- Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: the impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother. 2007;51(10):3510–3515
- Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis. 2003;37(6):745–751
- Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment (Analysis of 189 episodes). Arch Intern Med. 1996;156(18):2121–2126
- Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis. J Antimicrob Chemother. 2003;52(4):668–674
- Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med. 2005;165(3):308–313
- Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791–797
- Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother. 2005;49(4):1306–1311
- Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49(2):760–766
- . Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents. 1999;11(1):7–12
- Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol. 2003;24(12):890–896
- Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case-controlled study. J Infect Chemother. 1999;5(3):180–184
- . Performance Standards for Antimicrobial Susceptibility Testing, 15th informational supplement (CLSI/NCCLS document M100-S15). Wayne, PA: CLSI; 2005;
- Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 consecutive neutropenic patients with hematologic malignancies. Int J Infect Dis. 1998;3(2):99–104
- . Prescribing guidelines for severe Pseudomonas infections. J Antimicrob Chemother. 2002;49(2):229–233
- Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest. 2003;123(5):1615–1624
- Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest. 2004;125(2):607–616
HS Cheong and CI Kang contributed equally to the study.
PII: S0002-9343(08)00357-4
doi: 10.1016/j.amjmed.2008.03.034
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
The American Journal of Medicine
Volume 121, Issue 8
, Pages 709-714
, August 2008

